Issued Patents All Time
Showing 1–25 of 26 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12404241 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Massimo Ammirante, Sogole Bahmanyar, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +11 more | 2025-09-02 |
| 11873283 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Massimo Ammirante, Sogole Bahmanyar, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +11 more | 2024-01-16 |
| 11590139 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang +11 more | 2023-02-28 |
| 11331380 | Cereblon-based heterodimerizable chimeric antigen receptors | — | 2022-05-17 |
| 11325889 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Massimo Ammirante, Sogole Bahmanyar, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +11 more | 2022-05-10 |
| 11166950 | Treatment of cancer with TOR kinase inhibitors | Kristen Mae Hege, Heather Raymon, Rama Krishna Narla, Rajesh Chopra | 2021-11-09 |
| 11149007 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Massimo Ammirante, Sogole Bahmanyar, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +11 more | 2021-10-19 |
| 10940152 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang +11 more | 2021-03-09 |
| 10646493 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang +11 more | 2020-05-12 |
| 10576085 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | John Frederick Boylan, Gordon L. Bray, Ellen Filvaroff, Robert Hubbard, David P. Mikolon +6 more | 2020-03-03 |
| 10004735 | Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines | Kimberly Fultz, Tam Minh Tran, Weiming Xu | 2018-06-26 |
| 9980963 | Treatment of cancer with dihydropyrazino-pyrazines | Heather Raymon, Antonia Lopez-Girona, Toshiya Tsuji, Kristen Mae Hege | 2018-05-29 |
| 9937170 | Treatment of cancer with TOR kinase inhibitors | Kristen Mae Hege, Antonia Lopez-Girona, Heather Raymon, Rama Krishna Narla, Rajesh Chopra | 2018-04-10 |
| 9795607 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more | 2017-10-24 |
| 9737535 | Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines | Kimberly Fultz, Tam Minh Tran, Weiming Xu | 2017-08-22 |
| 9737541 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Sogole Bahmanyar, Joshua Hansen, Dehua Huang, Robert Hubbard +11 more | 2017-08-22 |
| 9623028 | Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof | Dan Zhu, John Frederick Boylan, Jennifer Riggs, Tao Shi, Andrew Wurmser +2 more | 2017-04-18 |
| 9555033 | Identification of LKB1 mutation as a predictive biomarker for sensitivity to TOR kinase inhibitors | Rajesh Chopra, Yuhong Ning, Sabita Sankar, Weiming Xu | 2017-01-31 |
| 9557338 | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for tor kinase inhibitory activity | Weiming Xu, Deborah Mortensen, Kimberly Fultz | 2017-01-31 |
| 9512124 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Sogole Bahmanyar, Joshua Hansen, Dehua Huang, Robert Hubbard +11 more | 2016-12-06 |
| 9505764 | Treatment of cancer with dihydropyrazino-pyrazines | Heather Raymon, Antonia Lopez-Girona, Toshiya Tsuji, Kristen Mae Hege | 2016-11-29 |
| 9493466 | Treatment of cancer with TOR kinase inhibitors | Kristen Mae Hege, Antonia Lopez-Girona, Heather Raymon, Rama Krishna Narla, Rajesh Chopra | 2016-11-15 |
| 9428509 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more | 2016-08-30 |
| 9375443 | Method for treating advanced non-small cell lung cancer (NSCLC) by administering a combination of a TOR kinase inhibitor and azacitidine or erlotinib | Kristen Mae Hege, Tam Minh Tran | 2016-06-28 |
| 9346812 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more | 2016-05-24 |